RBD5044 for mixed high cholesterol and triglycerides
Part of Hormones & metabolism clinical trials.
This trial tests a new medication called RBD5044 for people with mixed dyslipidemia (high levels of fats and cholesterol in the blood). It may help lower triglycerides and cholesterol when statins aren't enough.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old.
- Your fasting triglyceride level is between 150 and 499 mg/dL.
- Your non-HDL cholesterol is 100 mg/dL or higher, or your LDL cholesterol is 70 mg/dL or higher, despite being on a stable statin (with or without ezetimibe) for at least 4 weeks.
- Your body mass index (BMI) is between 18 and 40.
- You do not have uncontrolled high blood pressure, serious mental illness, or active hepatitis B, C, or HIV.
- Your liver and kidney function tests are within certain limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, CTX310, for people with persistently high levels of fats (triglycerides) and cholesterol that have not improved with standard treatments. It aims to see if the drug is safe and tolerable.
This trial tests a new medication (QLC7401) for people with high cholesterol that is not well controlled by their current treatment. It aims to see if the drug can help lower LDL-C (bad cholesterol) levels and reduce the risk of heart problems.
This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.
This study tests how a new drug moves through the body and affects cholesterol levels. It is for people with moderately high cholesterol who are otherwise healthy.
This trial tests a new drug called HS-10582 in healthy people and those with slightly high LDL cholesterol (a type of cholesterol). The goal is to see if it is safe and how well your body handles it.
This trial tests an experimental drug, QLC7401, for people with high LDL cholesterol that hasn't lowered enough with current treatments. It aims to see if the drug can help reduce cholesterol levels in patients who are already on stable cholesterol medication.
Hear when a new Dyslipidemias trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.